JP2018500324A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500324A5 JP2018500324A5 JP2017532057A JP2017532057A JP2018500324A5 JP 2018500324 A5 JP2018500324 A5 JP 2018500324A5 JP 2017532057 A JP2017532057 A JP 2017532057A JP 2017532057 A JP2017532057 A JP 2017532057A JP 2018500324 A5 JP2018500324 A5 JP 2018500324A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- composition
- compound
- independently selected
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14198240 | 2014-12-16 | ||
| EP14198240.5 | 2014-12-16 | ||
| PCT/EP2015/079586 WO2016096720A1 (en) | 2014-12-16 | 2015-12-14 | Compounds for use in the treatment of conditions associated with nadph oxidase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018500324A JP2018500324A (ja) | 2018-01-11 |
| JP2018500324A5 true JP2018500324A5 (cg-RX-API-DMAC7.html) | 2019-01-24 |
| JP6768662B2 JP6768662B2 (ja) | 2020-10-14 |
Family
ID=52133887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532057A Active JP6768662B2 (ja) | 2014-12-16 | 2015-12-14 | Ｎａｄｐｈオキシダーゼに関連する状態の処置に使用するための化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10195167B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3233072A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6768662B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107405318A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2969051C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016096720A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019003826A (es) | 2016-10-06 | 2019-10-30 | Basf Se | Proceso para enriquecer enantiómeros de una mezcla de enantiómeros. |
| CA3099093A1 (en) * | 2018-05-09 | 2019-11-14 | Glucox Biotech Ab | Novel sulfonamide derivatives having selective nox inhibiting activity |
| CN118178506B (zh) * | 2024-03-18 | 2025-09-12 | 山东中医药大学附属医院 | 升麻提取物、灵芝多糖和nadph联合使用在制备治疗重症脓毒症药物中的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1756025A1 (en) | 2004-05-05 | 2007-02-28 | Novo Nordisk A/S | Sulfonamide derivatives |
| EP2420494B1 (en) * | 2006-08-16 | 2014-10-08 | The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone | Use of thiadiazole compounds as inhibitors of kynurenine-3-monooxygenase |
| CN101817767A (zh) | 2009-02-26 | 2010-09-01 | 中国科学院上海药物研究所 | 取代磺酰胺类化合物及其制备方法、药物组合物和应用 |
| KR101298651B1 (ko) * | 2011-03-16 | 2013-08-21 | 연세대학교 산학협력단 | 효능이 강화된 혈관신생 억제용 약제학적 조성물 |
| WO2014047110A2 (en) * | 2012-09-20 | 2014-03-27 | Temple University - Of The Commonwealth System Of Higher Education | Substituted alkyl diaryl derivatives, methods of preparation and uses |
| WO2014064118A1 (en) * | 2012-10-24 | 2014-05-01 | Glucox Biotech Ab | Triazine derivatives for the treatment of conditions associated with nicotinamide adenine dinucleotide phosphate oxidase |
-
2015
- 2015-12-14 JP JP2017532057A patent/JP6768662B2/ja active Active
- 2015-12-14 CN CN201580069060.1A patent/CN107405318A/zh active Pending
- 2015-12-14 US US15/535,524 patent/US10195167B2/en active Active
- 2015-12-14 WO PCT/EP2015/079586 patent/WO2016096720A1/en not_active Ceased
- 2015-12-14 EP EP15808420.2A patent/EP3233072A1/en active Pending
- 2015-12-14 CA CA2969051A patent/CA2969051C/en active Active